| 前收市價 | 1.6900 |
| 開市 | 1.6800 |
| 買盤 | 1.6400 |
| 賣出價 | 1.7500 |
| 拍板 | 29.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 1.6600 - 1.7700 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 5.31k |
BenzingaPfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose France” business summit. Together with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87 billion which is more than $2 billion to expand their operations in the country. AstraZeneca committed 365 million euros, which is about $394 mi
Motley Fool2 Top Growth Stocks Down 24% and 50% to Buy With $100
Investors might be remiss to overlook these stocks.
- Reuters
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday. The settlement was disclosed in a court filing in Delaware last week, and is aimed at reducing Pfizer's potential liability, the report added. Pfizer did not immediately reply to Reuters' request for comment.
